Enhanced Medical Sealant Glue for Improved Wound Healing

Publication ID: 24-11857693_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Medical Sealant Glue for Improved Wound Healing,” Published Technical Disclosure No. 24-11857693_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857693_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,693.

Summary of the Inventive Concept

The present invention relates to an improved medical sealant glue capable of promoting wound healing with enhanced gelation time, swelling ratio, mechanical properties, and bioactive peptide incorporation, thereby providing a more efficient and effective wound healing process.

Background and Problem Solved

The original patent disclosed a medical sealant glue capable of promoting wound healing. However, the original glue had limitations in terms of gelation time, swelling ratio, and mechanical properties, which hindered its widespread adoption. The present invention addresses these limitations by introducing improvements to the glue's formulation and preparation method.

Detailed Description of the Inventive Concept

The enhanced medical sealant glue comprises a crosslinked compound of a first component containing nucleophilic functional groups and a second component containing electrophilic functional groups. The glue is formulated to have improved gelation time, reduced by at least 30% compared to the original glue. Additionally, the glue is designed to have an increased swelling ratio in PBS solution, promoting wound healing. The glue may also incorporate a bioactive peptide to further enhance the wound healing process. The preparation method of the glue is optimized to reduce the gelation time and improve the swelling ratio of the resulting glue.

Novelty and Inventive Step

The present invention provides a novel and non-obvious solution to the limitations of the original medical sealant glue. The improvements in gelation time, swelling ratio, and mechanical properties, as well as the incorporation of bioactive peptides, provide a significant advancement in the field of wound healing.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include varying the type and concentration of the bioactive peptide, using different biocompatible fibers to reinforce the glue, or modifying the preparation method to achieve optimal gelation time and swelling ratio.

Potential Commercial Applications and Market

The enhanced medical sealant glue has significant commercial potential in the wound care industry, particularly in the treatment of chronic wounds, surgical wounds, and burns. The glue's improved properties make it an attractive solution for healthcare providers seeking to accelerate wound healing and reduce healthcare costs.

CPC Classifications

SectionClassGroup
A A61 A61L24/043
A A61 A61K35/28
A A61 A61L24/0005

Field of Art

Biomedical materials and wound healing technologies, specifically medical sealant compositions with a focus on crosslinked polymeric systems and regenerative medicine approaches

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or materials scientist with expertise in polymer chemistry, wound healing technologies, and medical device development, holding at least a Master's degree with 3-5 years of specialized experience in biomaterial design and medical adhesive formulations

Obviousness Rationale

A person of ordinary skill would recognize that the PTD's modifications to the medical sealant glue represent predictable variations within the established technological framework of the source patent. The disclosed improvements in gelation time, swelling ratio, and incorporation of bioactive peptides are logical extensions of known techniques in wound healing materials. These modifications would be considered routine optimization and design choices for a skilled practitioner seeking to enhance medical sealant performance.

Obvious Combinations & Variations

Source Patent Element
Crosslinked compound with nucleophilic and electrophilic functional groups
PTD Variation
Optimizing gelation time by modifying component ratios and mixing process
Obviousness Reasoning
Adjusting reaction kinetics and component concentrations is a standard engineering approach for controlling crosslinking, representing a predictable result within known polymer chemistry techniques
Source Patent Element
Medical sealant using dendritic molecules and exosomes
PTD Variation
Incorporating additional bioactive peptides to enhance wound healing properties
Obviousness Reasoning
Introducing supplementary bioactive components is a well-established strategy in regenerative medicine for improving tissue repair mechanisms, representing a known technique for enhancing medical materials
Source Patent Element
Chitosan-based medical sealant composition
PTD Variation
Modifying swelling ratio in PBS solution through polymer network design
Obviousness Reasoning
Controlling hydrogel swelling characteristics through polymer composition is a routine design choice for materials scientists, with predictable methods of achieving desired physical properties
Source Patent Element
Polyethylene glycol crosslinking components
PTD Variation
Reinforcing glue with biocompatible fibers to improve mechanical properties
Obviousness Reasoning
Enhancing mechanical performance through fiber reinforcement is a standard approach in biomaterial design, representing a finite and predictable solution for improving material strength
Source Patent Element
Wound healing medical sealant glue
PTD Variation
Reducing gelation time by 30% through optimized preparation method
Obviousness Reasoning
Systematic reduction of reaction time through process optimization is a typical engineering approach, representing a predictable outcome for a skilled practitioner
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in the Published Technical Disclosure render obvious any patent claims directed to medical sealant glue compositions with enhanced gelation characteristics, bioactive peptide incorporation, or modified mechanical properties, as substantiated by the teachings of US Patent 11857693 and the systematic optimization techniques evident in the prior art.

Original Patent Information

Patent NumberUS 11,857,693
TitleMedical sealant glue capable of promoting wound healing and preparation method thereof
Assignee(s)Shandong Branden Medical Device Co.,Ltd